This document discusses respiratory distress and respiratory failure. Respiratory distress refers to increased work of breathing, while respiratory failure is the inability of the lungs to provide oxygen or remove carbon dioxide. Respiratory failure can be acute or chronic. It can occur due to problems with the respiratory pump (central nervous system issues, muscle weakness) or due to airway/lung dysfunction (conditions affecting gas exchange like asthma, pneumonia). Proper monitoring of patients with respiratory distress or failure includes clinical examination, blood gas analysis, and oximetry. Immediate treatment of acute respiratory failure focuses on oxygenation and ventilation. Chronic respiratory failure often has a more insidious onset and requires careful monitoring, especially during sleep or illness.
Chronic obstructive pulmonary disease (COPD) refers to two lung diseases, chronic bronchitis and emphysema, that are typically caused by smoking. In COPD, airflow to the lungs is limited by narrowing of the airways and destruction of lung tissue, causing shortness of breath. The main symptoms include cough, sputum production, wheezing, and chest tightness. COPD is diagnosed through lung function tests and imaging. Treatment focuses on improving ventilation with bronchodilators, corticosteroids, and oxygen therapy. Managing symptoms and preventing complications are also important aspects of COPD care.
Chronic obstructive pulmonary disease (COPD) refers to two lung diseases, chronic bronchitis and emphysema, that are typically caused by smoking and limit airflow. In COPD, the airways and air sacs within the lungs are damaged, making it difficult to breathe. The document discusses the causes, symptoms, diagnosis, and treatment of COPD, including medications and surgery to improve lung function and quality of life. Nursing care focuses on improving ventilation, clearing secretions, managing anxiety and activity intolerance, and preventing complications like infection.
This document covers several topics related to respiratory pathophysiology:
1. It describes the anatomy and control of breathing, including the medullary respiratory center and pontine and apneustic areas.
2. Various types of breathing patterns are defined, such as Cheyne-Stokes respirations and Biot's respiration, along with the areas of brain injury that cause each pattern.
3. Common respiratory symptoms like cough, dyspnea, and hemoptysis are discussed alongside their typical causes.
4. Physical exam findings on chest auscultation and percussion are outlined, including vocal fremitus and lung sounds.
5. The calculation of the alveolar-arterial oxygen
The document discusses chronic obstructive pulmonary disease (COPD), which refers to two lung diseases - chronic bronchitis and emphysema - that cause airflow blockage and breathing-related problems. COPD risk factors include smoking, air pollution, and genetic conditions. Symptoms involve shortness of breath, chronic cough, and wheezing. Diagnosis involves lung function tests and chest imaging. Treatment focuses on improving ventilation and managing symptoms.
The document discusses respiratory failure and its management. It begins by defining respiratory failure and describing the types. It then lists common causes and presents results of diagnostic tests for a patient, including abnormal blood gases, imaging findings, and clinical signs. Treatment for this patient's respiratory failure included mechanical ventilation, bronchodilators, diuretics, and oxygen therapy. Complications of respiratory failure mentioned include cardiac or respiratory arrest.
This document discusses respiratory failure, which occurs when the respiratory system fails in gas exchange. It outlines the components of the respiratory system and centers in the brainstem that control breathing. There are four types of respiratory failure described based on gas exchange abnormalities: hypoxemic, hypercapnic, perioperative, and respiratory failure in shock. Diagnosis involves arterial blood gas analysis and evaluating for underlying causes. Treatment focuses on supporting oxygenation and ventilation, treating specific causes, and mechanical ventilation if needed.
This document discusses respiratory distress and respiratory failure. Respiratory distress refers to increased work of breathing, while respiratory failure is the inability of the lungs to provide oxygen or remove carbon dioxide. Respiratory failure can be acute or chronic. It can occur due to problems with the respiratory pump (central nervous system issues, muscle weakness) or due to airway/lung dysfunction (conditions affecting gas exchange like asthma, pneumonia). Proper monitoring of patients with respiratory distress or failure includes clinical examination, blood gas analysis, and oximetry. Immediate treatment of acute respiratory failure focuses on oxygenation and ventilation. Chronic respiratory failure often has a more insidious onset and requires careful monitoring, especially during sleep or illness.
Chronic obstructive pulmonary disease (COPD) refers to two lung diseases, chronic bronchitis and emphysema, that are typically caused by smoking. In COPD, airflow to the lungs is limited by narrowing of the airways and destruction of lung tissue, causing shortness of breath. The main symptoms include cough, sputum production, wheezing, and chest tightness. COPD is diagnosed through lung function tests and imaging. Treatment focuses on improving ventilation with bronchodilators, corticosteroids, and oxygen therapy. Managing symptoms and preventing complications are also important aspects of COPD care.
Chronic obstructive pulmonary disease (COPD) refers to two lung diseases, chronic bronchitis and emphysema, that are typically caused by smoking and limit airflow. In COPD, the airways and air sacs within the lungs are damaged, making it difficult to breathe. The document discusses the causes, symptoms, diagnosis, and treatment of COPD, including medications and surgery to improve lung function and quality of life. Nursing care focuses on improving ventilation, clearing secretions, managing anxiety and activity intolerance, and preventing complications like infection.
This document covers several topics related to respiratory pathophysiology:
1. It describes the anatomy and control of breathing, including the medullary respiratory center and pontine and apneustic areas.
2. Various types of breathing patterns are defined, such as Cheyne-Stokes respirations and Biot's respiration, along with the areas of brain injury that cause each pattern.
3. Common respiratory symptoms like cough, dyspnea, and hemoptysis are discussed alongside their typical causes.
4. Physical exam findings on chest auscultation and percussion are outlined, including vocal fremitus and lung sounds.
5. The calculation of the alveolar-arterial oxygen
The document discusses chronic obstructive pulmonary disease (COPD), which refers to two lung diseases - chronic bronchitis and emphysema - that cause airflow blockage and breathing-related problems. COPD risk factors include smoking, air pollution, and genetic conditions. Symptoms involve shortness of breath, chronic cough, and wheezing. Diagnosis involves lung function tests and chest imaging. Treatment focuses on improving ventilation and managing symptoms.
The document discusses respiratory failure and its management. It begins by defining respiratory failure and describing the types. It then lists common causes and presents results of diagnostic tests for a patient, including abnormal blood gases, imaging findings, and clinical signs. Treatment for this patient's respiratory failure included mechanical ventilation, bronchodilators, diuretics, and oxygen therapy. Complications of respiratory failure mentioned include cardiac or respiratory arrest.
This document discusses respiratory failure, which occurs when the respiratory system fails in gas exchange. It outlines the components of the respiratory system and centers in the brainstem that control breathing. There are four types of respiratory failure described based on gas exchange abnormalities: hypoxemic, hypercapnic, perioperative, and respiratory failure in shock. Diagnosis involves arterial blood gas analysis and evaluating for underlying causes. Treatment focuses on supporting oxygenation and ventilation, treating specific causes, and mechanical ventilation if needed.
This document discusses respiratory failure, which occurs when the respiratory system fails in gas exchange. It defines two main types - hypoxemic respiratory failure, defined as low blood oxygen, and hypercapnic respiratory failure, defined as high blood carbon dioxide. The document then covers the anatomy and physiology of respiration, diagnostic evaluation of respiratory failure, treatment including mechanical ventilation, and specific causes of respiratory failure like infection, airway obstruction, and cardiac issues.
Acute respiratory failure happens quickly and without much warning. It is often caused by a disease or injury that affects your breathing, such as pneumonia, opioid overdose, stroke, or a lung or spinal cord injury. Respiratory failure can also develop slowly
The document provides education on using continuous positive airway pressure (CPAP) devices to treat patients experiencing respiratory distress or failure, outlining the anatomy and physiology of respiration, common respiratory disorders, how CPAP works to apply positive pressure and alleviate symptoms, appropriate indications and contraindications for its use, and tips for effective operation of CPAP devices in the pre-hospital setting. The goal is for EMT providers to correctly utilize CPAP to improve oxygenation and reduce the workload of breathing for compromised patients.
RESPIRATORY FAILURE of all 4 types .pptxshaikashraf14
1. Respiratory failure is a condition where the respiratory system fails in gas exchange due to dysfunction of respiratory components.
2. The respiratory center located in the brainstem controls rhythmic breathing through various centers that regulate rate and depth.
3. Chemoreceptors in the brainstem and carotid/aortic bodies sense changes in blood gases and stimulate breathing in response to hypoxia and hypercapnia.
4. The type of respiratory failure is classified based on blood gas abnormalities and can be hypoxemic, hypercapnic, or involve both.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by airflow obstruction that is generally progressive and may be partially reversible. It includes emphysema and chronic bronchitis. The primary cause is cigarette smoking which damages the lungs over many years through destruction of lung tissue and increased inflammation. Symptoms include dyspnea, cough, and limited physical activity. Treatment focuses on smoking cessation and medications to relieve symptoms along with respiratory therapy and oxygen as needed.
COPD is a progressive lung disease defined by abnormal airflow that worsens over time. It encompasses chronic bronchitis and emphysema and is usually caused by smoking or air pollution. Symptoms include a chronic cough, shortness of breath, wheezing and chest tightness. Diagnosis involves lung function tests showing reduced airflow. Treatment focuses on stopping smoking and medications to relieve symptoms.
This document discusses pediatric ventilation basics including anatomy, physiology, pathophysiology, and terminology. Key points include: the pediatric airway is smaller and more anteriorly placed; children have higher oxygen needs and lower tolerance for hypoxia; compliance is lower in children; and ventilator settings like tidal volume, rate, inspiratory time, and PEEP must be adjusted for pediatric patients. Common pediatric lung conditions and how they impact pulmonary function tests and the ventilation/perfusion ratio are also reviewed.
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by airflow obstruction that is generally progressive and may be partially reversible. It includes emphysema and chronic bronchitis. Cigarette smoking is the primary cause of COPD and damages the lungs through various mechanisms. Pathophysiology involves destruction of lung tissue and narrowing of airways. Symptoms include dyspnea, cough, and limited physical activity. Treatment focuses on smoking cessation, bronchodilators, oxygen therapy, breathing exercises, nutrition management, and pulmonary rehabilitation.
Examinating the Resipiratory System.pptxssuser504dda
This document provides guidance on examining the respiratory system through history taking and physical examination. It details what to ask patients regarding symptoms like breathlessness, cough, sputum production, and chest pain. It also explains how to inspect, palpate, percuss and auscultate the chest. Specific tests are described like measuring chest expansion, examining neck veins, and evaluating breath sounds and vocal fremitus. A thorough respiratory exam provides clues to underlying cardiopulmonary conditions.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by airflow obstruction and breathlessness. It encompasses chronic bronchitis and emphysema and is usually caused by smoking. Symptoms include chronic cough, sputum production, shortness of breath, wheezing and chest tightness. Diagnosis involves lung function tests showing reduced airflow and chest imaging may show signs of emphysema like bullae. Treatment focuses on smoking cessation and medications can provide short-term relief of exacerbations and long-term management of symptoms.
8. Respiratory failure in human body.pptShinilLenin
This document discusses respiratory failure (RF), including its definition, classification, causes, diagnosis, and management. RF is defined as failure of oxygenation or carbon dioxide elimination, and is classified as type 1 (hypoxemic) or type 2 (hypercapnic). Causes of acute RF include hypoventilation, V/Q mismatching, intrapulmonary shunting, and diffusion abnormalities. Diagnosis involves clinical presentation, arterial blood gases, imaging, and investigating underlying causes. Management focuses on airway support, oxygenation, ventilation, treating the underlying condition, and weaning from support as clinical status improves.
This document discusses chronic obstructive pulmonary disease (COPD) and considerations for anesthesia. It defines COPD and describes related conditions like chronic bronchitis and emphysema. It covers risk factors, pathogenesis, pathophysiology including airway obstruction, hyperinflation, and gas exchange impairment. Clinical features, investigations, disease classification, and treatment approaches including smoking cessation and bronchodilators are summarized. Key points for anesthetists regarding airway challenges, ventilation/perfusion abnormalities, and development of auto-PEEP are highlighted.
Chronic obstructive pulmonary disease (COPD) is a common lung disease characterized by airflow limitation that is usually progressive. It is the third leading cause of death in the United States. The two main conditions that make up COPD are chronic bronchitis and emphysema. Cigarette smoking is the leading risk factor. Symptoms include dyspnea, chronic cough, and sputum production. Diagnosis is confirmed by spirometry showing airflow limitation. Management focuses on smoking cessation, bronchodilators, glucocorticoids, pulmonary rehabilitation, oxygen therapy, and managing exacerbations and comorbidities.
The document provides information on assessing the respiratory system through history and physical examination. It describes the key symptoms of respiratory disease including chest pain, dyspnea, cough, wheeze, sputum production, and hemoptysis. It outlines how to evaluate these symptoms and what they may indicate. It also details the physical examination of the respiratory system, covering inspection, palpation, percussion, and auscultation of the chest and other relevant body systems. The document is a guide for comprehensively assessing the respiratory system in clinical practice.
This document discusses respiratory failure, which occurs when the respiratory system fails in gas exchange. It defines two main types - hypoxemic respiratory failure, defined as low blood oxygen, and hypercapnic respiratory failure, defined as high blood carbon dioxide. The document then covers the anatomy and physiology of respiration, diagnostic evaluation of respiratory failure, treatment including mechanical ventilation, and specific causes of respiratory failure like infection, airway obstruction, and cardiac issues.
Acute respiratory failure happens quickly and without much warning. It is often caused by a disease or injury that affects your breathing, such as pneumonia, opioid overdose, stroke, or a lung or spinal cord injury. Respiratory failure can also develop slowly
The document provides education on using continuous positive airway pressure (CPAP) devices to treat patients experiencing respiratory distress or failure, outlining the anatomy and physiology of respiration, common respiratory disorders, how CPAP works to apply positive pressure and alleviate symptoms, appropriate indications and contraindications for its use, and tips for effective operation of CPAP devices in the pre-hospital setting. The goal is for EMT providers to correctly utilize CPAP to improve oxygenation and reduce the workload of breathing for compromised patients.
RESPIRATORY FAILURE of all 4 types .pptxshaikashraf14
1. Respiratory failure is a condition where the respiratory system fails in gas exchange due to dysfunction of respiratory components.
2. The respiratory center located in the brainstem controls rhythmic breathing through various centers that regulate rate and depth.
3. Chemoreceptors in the brainstem and carotid/aortic bodies sense changes in blood gases and stimulate breathing in response to hypoxia and hypercapnia.
4. The type of respiratory failure is classified based on blood gas abnormalities and can be hypoxemic, hypercapnic, or involve both.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by airflow obstruction that is generally progressive and may be partially reversible. It includes emphysema and chronic bronchitis. The primary cause is cigarette smoking which damages the lungs over many years through destruction of lung tissue and increased inflammation. Symptoms include dyspnea, cough, and limited physical activity. Treatment focuses on smoking cessation and medications to relieve symptoms along with respiratory therapy and oxygen as needed.
COPD is a progressive lung disease defined by abnormal airflow that worsens over time. It encompasses chronic bronchitis and emphysema and is usually caused by smoking or air pollution. Symptoms include a chronic cough, shortness of breath, wheezing and chest tightness. Diagnosis involves lung function tests showing reduced airflow. Treatment focuses on stopping smoking and medications to relieve symptoms.
This document discusses pediatric ventilation basics including anatomy, physiology, pathophysiology, and terminology. Key points include: the pediatric airway is smaller and more anteriorly placed; children have higher oxygen needs and lower tolerance for hypoxia; compliance is lower in children; and ventilator settings like tidal volume, rate, inspiratory time, and PEEP must be adjusted for pediatric patients. Common pediatric lung conditions and how they impact pulmonary function tests and the ventilation/perfusion ratio are also reviewed.
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by airflow obstruction that is generally progressive and may be partially reversible. It includes emphysema and chronic bronchitis. Cigarette smoking is the primary cause of COPD and damages the lungs through various mechanisms. Pathophysiology involves destruction of lung tissue and narrowing of airways. Symptoms include dyspnea, cough, and limited physical activity. Treatment focuses on smoking cessation, bronchodilators, oxygen therapy, breathing exercises, nutrition management, and pulmonary rehabilitation.
Examinating the Resipiratory System.pptxssuser504dda
This document provides guidance on examining the respiratory system through history taking and physical examination. It details what to ask patients regarding symptoms like breathlessness, cough, sputum production, and chest pain. It also explains how to inspect, palpate, percuss and auscultate the chest. Specific tests are described like measuring chest expansion, examining neck veins, and evaluating breath sounds and vocal fremitus. A thorough respiratory exam provides clues to underlying cardiopulmonary conditions.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by airflow obstruction and breathlessness. It encompasses chronic bronchitis and emphysema and is usually caused by smoking. Symptoms include chronic cough, sputum production, shortness of breath, wheezing and chest tightness. Diagnosis involves lung function tests showing reduced airflow and chest imaging may show signs of emphysema like bullae. Treatment focuses on smoking cessation and medications can provide short-term relief of exacerbations and long-term management of symptoms.
8. Respiratory failure in human body.pptShinilLenin
This document discusses respiratory failure (RF), including its definition, classification, causes, diagnosis, and management. RF is defined as failure of oxygenation or carbon dioxide elimination, and is classified as type 1 (hypoxemic) or type 2 (hypercapnic). Causes of acute RF include hypoventilation, V/Q mismatching, intrapulmonary shunting, and diffusion abnormalities. Diagnosis involves clinical presentation, arterial blood gases, imaging, and investigating underlying causes. Management focuses on airway support, oxygenation, ventilation, treating the underlying condition, and weaning from support as clinical status improves.
This document discusses chronic obstructive pulmonary disease (COPD) and considerations for anesthesia. It defines COPD and describes related conditions like chronic bronchitis and emphysema. It covers risk factors, pathogenesis, pathophysiology including airway obstruction, hyperinflation, and gas exchange impairment. Clinical features, investigations, disease classification, and treatment approaches including smoking cessation and bronchodilators are summarized. Key points for anesthetists regarding airway challenges, ventilation/perfusion abnormalities, and development of auto-PEEP are highlighted.
Chronic obstructive pulmonary disease (COPD) is a common lung disease characterized by airflow limitation that is usually progressive. It is the third leading cause of death in the United States. The two main conditions that make up COPD are chronic bronchitis and emphysema. Cigarette smoking is the leading risk factor. Symptoms include dyspnea, chronic cough, and sputum production. Diagnosis is confirmed by spirometry showing airflow limitation. Management focuses on smoking cessation, bronchodilators, glucocorticoids, pulmonary rehabilitation, oxygen therapy, and managing exacerbations and comorbidities.
The document provides information on assessing the respiratory system through history and physical examination. It describes the key symptoms of respiratory disease including chest pain, dyspnea, cough, wheeze, sputum production, and hemoptysis. It outlines how to evaluate these symptoms and what they may indicate. It also details the physical examination of the respiratory system, covering inspection, palpation, percussion, and auscultation of the chest and other relevant body systems. The document is a guide for comprehensively assessing the respiratory system in clinical practice.
Similar to respiratory failure..... presentation by dr priyanka (20)
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
3. Respiratory failure
⦿ inability of the lungs to provide sufficient
oxygen (hypoxic respiratory failure) or
remove carbon dioxide (ventilatory failure)
to meet metabolic demands.
⦿ Inadequate oxygenation/ ventilation when
compensatory mechanism fail to maintain
gas exchange
4. Respiratory failure
⦿ Pao2 < 60 with breathing of room air
and
⦿ Paco2 > 50 resulting in acidosis,
⦿ the patient's general state, respiratory
effort, and potential for impending
exhaustion are more important indicators
than blood gas values.
5. ⦿ Respiratory distress can occur in
patients without respiratory disease,
and
⦿ respiratory failure can occur in patients
without respiratory distress.
6. The causes:
⦿ Respiratory load related to lung or
airway
⦿ conditions that affect the respiratory
pump failure (respiratory muscle
failure)
⦿ Related to central nervous system
8. Respiratory Pump Dysfunction
● Decreased Central Nervous System (CNS) Input
⦿ — Head injury
⦿ — Ingestion of CNS depressant
⦿ — Adverse effect of procedural sedation
⦿ — Intracranial bleeding
⦿ — Apnea of prematurity
● Peripheral Nerve/Neuromuscular Junction
⦿ — Spinal cord injury
⦿ — Organophosphate/carbamate poisoning
⦿ — Guillian-Barre´ syndrome
⦿ — Myasthenia gravis
⦿ — Infant botulism
● Muscle Weakness
⦿ — Respiratory muscle fatigue due to increased work of breathing
⦿ — Myopathies/Muscular dystrophies
9. Lung/Airway Disease
⦿ Diseases of the lung or airways affect gas
exchange most often by disrupting the normal
matching of V/Q or by causing a shunt.
⦿ usually can maintain a normal Paco2 as lung
disease worsens simply by breathing more.
⦿ hypoxemia is the hallmark of lung disease
10. Causes of hypoxia
⦿ Hypoxemia due to V/Q mismatch
⦿ Diffusion block
⦿ Hypoventilation
⦿ Right to left shunting
12. Diffusion
⦿ diffusion defects manifest as hypoxemia rather
than hypercarbia.
⦿ Refers to process that impair gas exchange at
alveolar membrane due to presence of fluid,
inflammatory infiltrates, surfactant dysfunction
⦿ Examples :
Interstitial pneumonia, ARDS, Surfactant
dysfunction, Pulmonary edema,…
13. Hypoventilation
⦿ Includes all condition causing pump failure
(neuromuscular weakness) causing respiratory
muscle dysfunction
⦿ low respiratory rate and shallow breathing are both
signs of hypoventilation.
⦿ The Paco2 increases in proportion to a decrease
in ventilation.
⦿ Pao2 falls approximately the same amount as
the Paco2 increases.
16. ABG & Oximetry
⦿ ABG /CBG/ VBG
⦿ Oximetry
- Oximetry provides an invaluable and usually
accurate measurement of oxygenation.
- important to recognize its technical limitations
19. ARF
⦿ most common cause of cardiac arrest in children.
When presented with a child who has:
⦿ a decreased level of consciousness,
⦿ slow/shallow breathing, or increased
⦿ respiratory drive, the possibility of
ARF should be considered
20. First:
⦿ to assure adequate gas exchange and
circulation (the ABCs).
⦿ Oxygen Administration to maintain … .
⦿ If Ventilation is or appears to be inadequate …..
⦿ Intubation ?
Need ICU
21. Arterial gas composition
depends on :
⦿ the gas composition of the atmosphere
⦿ the effectiveness of alveolar ventilation
⦿ pulmonary capillary perfusion
⦿ diffusion across the alveolar capillary
membrane
23. CRF
is seen most commonly in children who have:
⦿ Respiratory muscle weakness (muscular
dystrophy, anterior horn cell disease) or
⦿ severe chronic lung diseases (BPD, end-
stage cystic fibrosis)
24. ⦿ usually has an insidious onset
⦿ Most children do not have dyspnea.
⦿ PH normal or near normal , unless…..
⦿ Recognizing need careful monitoring
of children at risk for CRF
25. ⦿ Disordered sleep
⦿ Daytime hypersomnolence
⦿ Morning headaches
⦿ Altered mental status
⦿ Increased respiratory symptoms
⦿ Cardiomegaly
⦿ Decreased baseline oxygenation
⦿ CRF often presents first during sleep
⦿ Develops an intercurrent illness , Fever